Gene Therapy Facility Expansions Continue News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recorded Second Quarter Revenue of $34.8 Million Signed $26 Million in Net New Business Orders Resulting in a Backlog of $147 Million, an Increase of 23% Year-Over-Year Mammalian. | December 6, 2022

Oksana lukashNick greenMichael alston jrExchange commissionAvid bioservices incOncocyte corporationGlobenewswire incSecond quarter revenueNet new business orders resultingCell facilitiesGene therapy facility expansions continueQuarter endedAvid bioservice quarterly reportRegarding useAvid bioservicesAvid bioservices